Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-016380
Filing Date
2023-03-06
Accepted
2023-03-06 17:04:28
Documents
1
Period of Report
2023-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 22731
  Complete submission text file 0001209191-23-016380.txt   24074
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

EIN.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REATA PHARMACEUTICALS, INC. 2801 GATEWAY DR. SUITE 150 IRVING TX 75063
Business Address
Meyer Colin John (Reporting) CIK: 0001662392 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37785 | Film No.: 23709776